Legacy Wealth Partners (California)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,429
Closed -$789K 95
2020
Q4
$789K Buy
21,429
+15,385
+255% +$564K 0.5% 51
2020
Q3
$210K Buy
+6,044
New +$212K 0.15% 83
2020
Q2
Sell
-10,185
Closed -$315K 110
2020
Q1
$315K Buy
+10,185
New +$347K 0.29% 67

Other funds holding PFE

Legacy Wealth Partners (California)'s PFE Position: Q1 2021 in Review

Legacy Wealth Partners (California) sold out of Pfizer (PFE) in Q1 2021, closing a stake of 21,429 shares — an estimated $789K sold.

Legacy Wealth Partners (California) first reported a position in PFE in Q1 2020 and held it in 3 quarters. The position peaked at $789K in Q4 2020. 2,675 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

  • Legacy Wealth Partners (California) reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
  • Legacy Wealth Partners (California) sold 21,429 Pfizer shares in Q1 2021, an estimated $789K.
  • Legacy Wealth Partners (California) first reported a position in Pfizer in Q1 2020 and held it in 3 quarters.
  • Legacy Wealth Partners (California)'s Pfizer position peaked at $789K in Q4 2020.
  • 2,675 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on Legacy Wealth Partners (California)'s 13F filing for Q1 2021, filed 12 May 2021.